Travatan Versus Timoptic in Treating Open-angle Glaucoma or Ocular Hypertension

PHASE4CompletedINTERVENTIONAL
Enrollment

111

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2008

Conditions
Glaucoma
Interventions
DRUG

Travoprost 0.004% Ophthalmic Solution (Travatan)

Travoprost at 9 AM + Placebo \& 9 PM

DRUG

Timolol 0.5% Ophthalmic Solution (Timoptic)

Timolol in each eye, twice daily at 9 AM \& 9 PM

Trial Locations (1)

76134

Alcon Call Center, Fort Worth

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Alcon Research

INDUSTRY